Literature DB >> 12132080

Management of flexor tendon sheath ganglions: a cost analysis.

James G Bittner1, Richard Kang, Peter J Stern.   

Abstract

The purpose of this study was to determine success rates of 1 or more aspirations on flexor tendon sheath ganglions compared with surgical excision and to determine what treatment method is most cost-effective. Data were collected from documented history and physical examinations, operative reports, billing records, and telephone interviews. Of the 259 patients coded as having flexor tendon sheath ganglions, 175 met the inclusion criteria. In addition, 2001 Medicare-assigned relative value units and fees were used to calculate the most cost-effective treatment. Of the 141 patients treated with aspiration, 66% exhibited no recurrence after 2 consecutive treatments. Thirteen of 14 patients (93%) who had ganglions excised without prior aspiration showed no recurrence. All 29 patients who had excision after 1 (n = 24) or 2 (n = 5) failed aspirations were cured. Because few patients require excision after 2 aspirations, the most cost-effective treatment for recurrent flexor tendon sheath ganglions is 2 aspirations before excision.

Entities:  

Mesh:

Year:  2002        PMID: 12132080     DOI: 10.1053/jhsu.2002.34318

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  4 in total

1.  Modeling the management of a flexor sheath ganglion.

Authors:  Ping Xu; Ling Lan; Steven J McCabe
Journal:  Hand (N Y)       Date:  2007-07-11

2.  Flexor tendon sheath ganglions: results of surgical excision.

Authors:  Peter J L Jebson; Edwin E Spencer
Journal:  Hand (N Y)       Date:  2007-03-23

3.  Cost minimisation using clinic-based treatment for common hand conditions--a prospective economic analysis.

Authors:  J A Webb; J Stothard
Journal:  Ann R Coll Surg Engl       Date:  2008-12-19       Impact factor: 1.891

4.  Surgery for ganglia of the flexor tendon sheath.

Authors:  Vilhjalmur Finsen; Oyvind Håberg; Grethe Elisabeth Borchgrevink
Journal:  Orthop Rev (Pavia)       Date:  2013-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.